ChemDiv, Inc. Announces Collaboration With Scripps Florida
SAN DIEGO, July 21 /PRNewswire/ — ChemDiv, Inc. (ChemDiv), a global
chemistry-driven contract research organization with headquarters in San
Diego, California, has announced the extension of its collaboration with Palm
Beach County-based Scripps Florida, the newly established division of the
Scripps Research Institute of La Jolla, California.
Under the terms of the agreement, Scripps Florida is granted access to the
diverse and focused screening libraries designed by ChemDiv. To support
further development, ChemDiv offers synthetic, medicinal chemistry as well as
its global logistics services for researchers at Scripps Florida. The
financial details of the agreement were not disclosed.
Alex Kiselyov, Ph.D., Vice President of Global Chemistry, ChemDiv, stated:
“We are pleased that Scripps Research has chosen to expand its relationship
with ChemDiv, to support Scripps Florida. We value our long-standing
association with Scripps Research, and consider it evidence of the high
quality standards we strive to provide our customers.”
About ChemDiv, Inc.
ChemDiv, Inc. (ChemDiv) is a global chemistry-driven contract research
organization focused on scientific innovation, and the delivery of products
and services that meet the drug discovery needs of its partners. ChemDiv
provides its partners access to Discovery outSource(TM) a full service drug
discovery capability encompassing; medicinal chemistry; pre-clinical
development; synthetic chemistry; diverse and focused screening libraries, as
well as global logistics. For additional information, please visit
http://www.chemdiv.com.
About The Scripps Research Institute
The Scripps Research Institute, headquartered in La Jolla, California, in
14 buildings on 100 acres overlooking the Pacific Ocean, is one of the world’s
largest independent, non-profit biomedical research organizations. It stands
at the forefront of basic biomedical science that seeks to comprehend the most
fundamental processes of life. Scripps Research is internationally recognized
for its research into immunology, molecular and cellular biology, chemistry,
neurosciences, autoimmune, cardiovascular, and infectious diseases, and
synthetic vaccine development. Established in its current configuration in
1961, it employs approximately 3,000 scientists, postdoctoral fellows,
scientific and other technicians, doctoral degree graduate students, and
administrative and technical support personnel.
Scripps Florida, a 364,000 square-foot, state-of-the-art biomedical
research facility, will be built in the near future in Palm Beach County. The
facility will focus on basic biomedical science, drug discovery, and
technology development. Palm Beach County and the State of Florida have
provided start-up economic packages for development, building, staffing, and
equipping the campus. Scripps Florida now operates with approximately 100
scientists, technicians, and administrative staff at 40,000 square-foot lab
facilities on the Florida Atlantic University campus in Jupiter.
SOURCE ChemDiv, Inc.
Web site: http://www.chemdiv.com
